Pharma stocks saw a significant uptick in early trading after the US House of Representatives passed the Biosecure Act, which aims to bolster the pharmaceutical supply chain and encourage domestic drug production. Investors reacted positively to the news, with major pharmaceutical companies showing gains in the market.
- Zydus Lifesciences (9:25 AM): Stock rose 0.9% to ₹1,114.10.
- Cipla (9:25 AM): Gained 0.58%, reaching ₹1,629.50.
- Lupin (9:25 AM): Increased by 0.97%, trading at ₹2,238.35.
- Divi’s Laboratories (9:26 AM): Led the gains with a 1.64% rise to ₹5,258.50.
- Laurus Labs (9:26 AM): Up 1.14%, at ₹496.55.
- Piramal Pharma (PPL Pharma) (9:26 AM): Surged 2.63%, trading at ₹223.05.
- Suven Pharmaceuticals (9:27 AM): Saw a strong 3.4% jump to ₹1,247.05.
With the passing of the Biosecure Act, Indian pharmaceutical companies are expected to benefit from increased opportunities in the US market, leading to a positive sentiment in the sector.
